England’s National Health Service is set to provide nivolumab as a rapid injection for cancer patients. This innovative approach reduces treatment time from an hour to just minutes, benefiting individuals with skin, bladder, and oesophagus cancers. Approximately 1,200 patients monthly can transition from traditional IV drips to this quicker injection method, maintaining efficiency while conserving NHS resources. Find out more about how this advancement is reshaping cancer care in England.